From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report - Top-Institutions - MDSpire

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report

  • By

  • Urszula Jedynak-Wąsowicz

  • Liliana Klim

  • Ewa Cichocka-Jarosz

  • May 29, 2026

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children’s Hospital Medical Center
    Cincinnati Children’s Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Allergy and Immunology
    • Pediatrics

  • #2

    Children’s Hospital of Philadelphia
    Children’s Hospital of Philadelphia

    Philadelphia, Pennsylvania

    Key Differentiators

    • Allergy and Immunology
    • Pediatrics

  • #3

    IRCCS Ospedale San Raffaele
    IRCCS Ospedale San Raffaele

    Milan, Italy

    Key Differentiators

    • Allergy and Immunology

  • #4

    Fox Chase Cancer Center
    Fox Chase Cancer Center

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology
    • Allergy and Immunology

  • #5

    University of Michigan
    University of Michigan

    Ann Arbor, Michigan

    Key Differentiators

    • Allergy and Immunology
    • Gastroenterology

Original Source(s)

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report

  • by Urszula Jedynak-Wąsowicz, Liliana Klim, Ewa Cichocka-Jarosz

  • May 29, 2026

Related Content

Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

One Pathway for Esophageal Cancer?

Molecular profiling reveals precursor signals in BE-negative esophageal cancer

  • May 7, 2026

  • 2 min